Albany, US, 2019-Oct-07 — /EPR Network/ —The human respiratory syncytial virus (RSV) is the key factor behind an estimated 3.4 million respiratory tract infections among [read full press release…]
Albany, USA, 2019-Oct-01 — /EPR Network/ — A newly compiled business intelligent report, titled “Respiratory Syncytial Virus Attachment Glycoprotein-Pipeline Review, H2 2019” has been publicized [read full press release…]
Albany, US, 2017-Jul-22 — /EPR Network/ — Market Research Hub includes new market research report “Respiratory Syncytial Virus Attachment Glycoprotein (RSV G or G) Pipeline Review, [read full press release…]
